Zurich, Switzerland and Turin, Italy – May 23, 2011: Leaders from the medtech industry gathered last week for the third annual EuroMedtech™ partnering conference, held May 16–17 at the Torino Incontra Conference Center in Turin, Italy. 261 delegates representing 205 companies from 27 countries engaged in 741 one-to-one partnering meetings, confirming EuroMedtech as the premier destination for forming partnerships between emerging innovator and start-up companies, and large multinational firms.

The event featured 8 panel discussions and 45 presentations by medical technology companies seeking financing, licensing opportunities or partners for advancing their product development.

The event also attracted over 20 leading venture capital firms, including 360° Capital Partners, BioMedPartners, Citigroup, DFJ Esprit, Edmond de Rothschild Investment Partners, Entrepreneurs Fund, Gilde Healthcare Partners, High-Tech Gruenderfonds Management, IJ Partners, Merieux Development, MVM Life Science Partners, NBGI Ventures, SEED Capital Denmark, Seventure Partners, SGECR, SHAM, Sofimac Partners Capital Investissement, TBG Management, Tech Coast Angels, Vaekstfonden, and Ysios Capital Partners.

"The impressive partnering activity at this year's EuroMedtech confirms a fundamental shift occurring in the medical technology space. Medtech companies are beginning to think of themselves as companies in the business of delivering health outcomes," said Carola Schropp, President of EBD Group. "This means that medtech firms are focused on partnering with a range of companies to develop products that are innovative, yet are valued by payors and regulators. Fundamentally, collaboration is becoming a competitive advantage for companies, and EuroMedtech provides the platform where those collaborations can get started."

The success of EuroMedtech 2011 sets the stage for next year's edition, which will be held in Grenoble, France.

About Regional Host Sponsor

The Torino Chamber of Commerce is a mission-driven public institution, representing the interests of the local economy that can count on 238,000 companies highly qualified in research, training and manufacturing. It creates value through initiatives that promote excellence abroad, mainly in the automotive, aerospace, IT and biomed sectors.

About EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:

• BIO-Europe^® and BIO-Europe Spring^®, the world's largest stand-alone life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
• BioPharm America™, the fastest growing partnering event in North America
• EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry
• BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
• ChinaBio^® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio^® LLC
• Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors

EBD Group’s sophisticated web-based partnering service, partneringONE^®, is used as the partnering engine at numerous third-party events around the world.

Outside of the conference format, EBD Group’s consultants provide hands-on assistance for firms seeking to in- or out-license products and technologies.

EBD Group has offices in the USA and Europe.

For more information please visit www.ebdgroup.com.

Contact:

Constantine Theodoropulos
EBD Group
+ 1 617 816 4637
ctheodoropulos@ebdgroup.com

Back to news